Inflammatory Markers Are Quickly Improved by Tocilizumab in Early Polymyalgia Rheumatica and Might Predict Early Response to Interleukin-6 Blockade
figure
posted on 2021-03-18, 11:56 authored by Adis journals on behalf of, Guillermo Carvajal Alegria, Divi Y. K Cornec, Yves Renaudineau, Alain Saraux, Valérie Devauchelle-Pensec<div><strong>Article full text</strong></div><div><br></div><div>The above summary slide represents the opinions of the authors. For a full list of declarations, including funding and author disclosure statements, please see the full text online (see “read the peer-reviewed publication” opposite). </div><div>© The authors, CC-BY-NC 2021. </div>
